LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $21,510 | -22.4% | 322 | 0.0% | 0.01% | -27.3% |
Q3 2022 | $27,727 | -3.2% | 322 | +0.3% | 0.01% | 0.0% |
Q2 2022 | $28,640 | -20.7% | 321 | 0.0% | 0.01% | -8.3% |
Q1 2022 | $36,109 | +10.3% | 321 | +51.4% | 0.01% | +9.1% |
Q4 2021 | $32,746 | -11.0% | 212 | -19.7% | 0.01% | -21.4% |
Q3 2021 | $36,780 | -54.3% | 264 | -9.9% | 0.01% | -73.6% |
Q3 2018 | $80,426 | +56.5% | 293 | +18.1% | 0.05% | +47.2% |
Q2 2018 | $51,378 | +25.4% | 248 | 0.0% | 0.04% | +24.1% |
Q1 2018 | $40,960 | +20.6% | 248 | 0.0% | 0.03% | +16.0% |
Q4 2017 | $33,959 | +0.6% | 248 | 0.0% | 0.02% | -3.8% |
Q3 2017 | $33,765 | +12.1% | 248 | 0.0% | 0.03% | +8.3% |
Q2 2017 | $30,107 | +37.4% | 248 | +19.8% | 0.02% | +33.3% |
Q1 2017 | $21,909 | +4.2% | 207 | 0.0% | 0.02% | -5.3% |
Q4 2016 | $21,033 | -0.4% | 207 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $21,126 | -14.4% | 207 | 0.0% | 0.02% | -17.4% |
Q2 2016 | $24,689 | +11.4% | 207 | 0.0% | 0.02% | +9.5% |
Q1 2016 | $22,168 | – | 207 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |